(Press-News.org) EUGENE, OR, October 1, 2010 – A newly published study in the October 2010 issue of The Journal of the American Dental Association (JADA), conducted at New York University's College of Dentistry, confirms the safety and efficacy of a new novel method for controlling xerostomia, or dry mouth. The double masked, randomized controlled crossover study concludes that use of a unique mucoadhesive patch, affixed to the hard palate inside the mouth, provides statistically significant and sustainable improvements in salivary flow rates and subjective moistness for dry mouth sufferers. An estimated 30 million Americans deal with this uncomfortable oral health condition.
This latest study comes on the heels of another published study (March 2010 issue of Quintessence International) that showed these patches provided better performance for dry mouth sufferers than a leading over-the-counter dry mouth spray.
Chronic dry mouth is an under-diagnosed condition that can have a detrimental effect on oral health by contributing to tooth decay, gum disease and chronic bad breath. It can be a symptom of other medical conditions, such as diabetes or Sjogren's Syndrome, and is also the result of radiation treatment for head and neck cancer, but it is most often a side effect of many prescription and over-the-counter medications taken daily by millions of Americans (34% of people on three or more medications will likely have this condition).
The mucoadhesive patches tested in the study are available to consumers under the brand name OraMoist™ and sold over-the-counter at retailers, such as Rite-Aid and Walgreen's, nationwide. Approximately one centimeter in diameter, the patches can adhere to any oral mucosal surface, such as the roof of the mouth or inside the cheek, and the study confirmed can yield a "statistically significant improvement in baseline subjective and objective measures of dry mouth for up to 60 minutes – and possibly longer – after application."
The JADA study also found that after two weeks of daily use, participants experienced a statistically significant improvement in baseline subjective and objective measures of salivary flow. This, according to the researchers, suggests a sustained effect.
"One of the results was that after two weeks of use of the patch, the amount of saliva in the mouth had increased even during times when there was no patch in the mouth," says the study's lead author A. Ross Kerr, DDS, MSD, clinical associate professor at New York University College of Dentistry. "In other words, the patch would seem to have a cumulative beneficial effect."
According to Dr. Kerr, OraMoist provides an appealing and convenient alternative to other dry mouth treatments, which are usually in spray, rinse or gel form and require the user to replenish when necessary – which can be up to every 20 minutes. Overnight, the sustained effect is of particular benefit.
"The OraMoist patches offer pleasant tasting and longer-lasting option for the management of dry mouth, which becomes a quality of life issue for sufferers," says Dr. Kerr. In this and the Quintessence International study, approximately 70% of participants stated they would use the patch again.
OraMoist Dry Mouth Patch is a time-released mucoadhesive patch that moistens and lubricates the mouth, while simultaneously stimulating saliva production, day or night. . The patch can last for up to four hours and is the only such sustained release dry mouth product available over-the-counter.
The placebo mucoadhesive patches used in this study were made using the same unique, patented technology as the OraMoist patches. Unlike the unloaded placebo patch, the loaded patch, OraMoist, is enhanced by natural ingredients including natural lipids, oral enzymes, citrus oil, sea salt, calcium carbonate, natural lemon and xylitol. According to the company, the researchers behind the patch believe that these additional ingredients also play a role in inhibiting bacterial growth and promoting oral health. Based on the results of this study, further investigation of these benefits is warranted.
The patented mucoadhesive patch technology was developed by Professor Abraham J. Domb, PhD, Institute of Drug Research, School of Pharmacy, Faculty of Medicine at the Hebrew University. Dr. Domb is a leading worldwide authority on mucoadhesive technology/bio-degradable polymer research. The same patch technology has also been successfully adapted for the treatment of aphtous ulcers, or canker sores.
INFORMATION:
SIDEBAR: JADA Study Findings Summary: Use of Mucoadhesive Patch for Relief of Chronic Dry Mouth
Significant increase in objectively-measured salivary flow rates in those using OraMoist
A "sustained effect" for OraMoist – the patients using it benefited more on their 4th and 5th weeks than on their 3rd; increased baseline of improvement
96% of patients said OraMoist was easy to use; 82% said OraMoist did not interfere with eating or talking; 74% said the flavor was pleasant.
OraMoist is safe. There were no adverse events reported in the study.
For more information about dry mouth and OraMoist, visit www.oramoist.com.
END
MINNEAPOLIS/ST.PAUL (October 1, 2010) – After a major review of scientific information, six leading tobacco research and policy experts have concluded that a nicotine reduction strategy should be an urgent research priority because of its potential to profoundly reduce the death and disease from tobacco use. Their findings were published today in the journal Tobacco Control.
According to this new report, reducing the amount of nicotine in cigarettes to non-addictive levels could have a significant public health impact on prevention and smoking cessation. Over time, ...
A calcium-sensing protein, STIM1, known to activate store-operated calcium channels has been found to also inhibit voltage-operated calcium channels, according to researchers at Temple University.
The researchers published their findings, The Calcium Store Sensor, STIM1, Reciprocally Controls Orai and Cav1.2 Channels, in the Oct. 1 issue of Science magazine (www.sciencemag.org).
Calcium, not just important for bones and teeth, is a universal signaling agent that is pivotal in controlling a wide range of cell functions including fast muscle and nerve responses and slower ...
An analysis of geological records that preserve details of the last known period of global warming has revealed 'startling' results which suggest current targets for limiting climate change are unsafe.
The study by climate change experts at the University of Exeter has important implications for international negotiators aiming to agree binding targets for future greenhouse gas emission targets.
Professor Chris Turney and Dr Richard Jones, both from the University's Department of Geography, have reported a comprehensive study of the Last Interglacial, a period of warming ...
The convergence in the coming year of three cyclical conditions affecting ocean temperatures and weather is likely to create unprecedented challenges for states that depend on water from the Colorado River, a new UCLA study suggests.
"If I were concocting a recipe for a perfect drought, this would be it," said Glen MacDonald, co-author of the study and director of UCLA's Institute of the Environment and Sustainability.
Along with a former graduate student, MacDonald has found that the combination of La Niña with two less commonly known ocean conditions — the Pacific ...
CORVALLIS, Ore. – Faster development of the promising field of cellulosic biofuels – the renewable energy produced from grasses and trees – is being significantly hampered by a "deep and thorny regulatory thicket" that makes almost impossible the use of advanced gene modification methods, researchers say.
In a new study published today in the journal BioScience, scientists argue that major regulatory reforms and possibly new laws are needed to allow cellulosic bioenergy to reach its true potential as a form of renewable energy, and in some cases help reduce greenhouse ...
BUFFALO, N.Y. -- Biomedical researchers at the University at Buffalo have engineered adult stem cells that scientists can grow continuously in culture, a discovery that could speed development of cost-effective treatments for diseases including heart disease, diabetes, immune disorders and neurodegenerative diseases.
UB scientists created the new cell lines – named "MSC Universal" – by genetically altering mesenchymal stem cells, which are found in bone marrow and can differentiate into cell types including bone, cartilage, muscle, fat, and beta-pancreatic islet cells. ...
ROCHESTER, Minn. -- In a review article published in the October issue of Mayo Clinic Proceedings,(http://www.mayoclinicproceedings.com) Mayo Clinic physicians differentiate the ethical and legal permissibility of withholding or withdrawing life-sustaining treatments and accepted comfort measures, specifically palliative sedation, from that of physician-assisted suicide or euthanasia.
Physician reviewers find that palliative sedation has an important place on the continuum of appropriate palliative care. "At the end of life, patient goals often shift to comfort, and removal ...
What does it take to save a species in the 21st century? The specter of climate change, with predicted losses to biodiversity as high as 35 percent, has some scientists and managers considering taking their conservation strategies on the road.
Managed relocation (MR) is literally the physical relocation of endangered or threatened species of plants and animals, by humans, to new, and foreign geographical climes. It addresses the concern that climate shifts may make many species' historical ranges environmentally inhospitable, and that the rapid speed of change and habitat ...
In a "marriage" that U.S. east coast residents would object to, the remnants of Tropical Storm Nicole coupled with an upper level low pressure area have dumped record rainfall from the Carolinas to New England on Sept. 30. The GOES-13 Satellite captured that massive "union" of a system as it begins to push off the northeastern U.S. coast today, Oct. 1.
At 1401 UTC (10:01 a.m. EDT) on Oct. 1, the Geostationary Operational Environmental Satellite called GOES-13 captured a visible image of the extensive cloud cover of this coupled system. The GOES image shows the system's ...
A major instrument due to fly aboard NASA's James Webb Space Telescope is getting its first taste of space in the test facilities at the Rutherford Appleton Laboratory (RAL) in the United Kingdom. The Mid-InfraRed Instrument (MIRI) has been designed to contribute to areas of investigation as diverse as the first light in the early Universe and the formation of planets around other stars.
"The start of space simulation testing of the MIRI is the last major engineering activity needed to enable its delivery to NASA. It represents the culmination of 8 years of work by the ...